BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports THIRD quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, November 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of f

Event · Earnings
Also in this documentDividend · regular · $0.15

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 12, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BGMS
Neutral
high confidence
Mentioned
$BGMS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BGMSNeutralMed
01

Why it matters

The Q3 release provides the first detailed financial snapshot post‑transition, offering traders fresh data to reassess valuation.

02

Market read

Micro‑cap earnings with modest loss improvement; primary relevance to BGMS investors and potential merger arbitrage.

03

What to watch

Pending business combination with Future NRG could materially change valuation if completed.

Relevance 7/10Novelty 6/10Timing: after‑hours November 12, 2026

Background

BGMS transitioned from biopharma to fire‑safety distribution and is pursuing a SPAC‑style business combination.

Company-level read

Ticker impact

$BGMSNeutralHigh confidence
Context

BGMS disclosed Q3 2026 financial results, narrowing net loss and reporting cash balance, in a primary 8‑K filing.

Expected impact

likely modest upward pressure as the market prices the narrowed loss and cash cushion

Evidence & confidence

The earnings release provides new quantitative data; loss halved and cash unchanged, which can attract short-covering and buyer interest.

Market effects

Improved results may signal resilience in niche fire‑safety distribution sector.

Limited to Malaysia‑focused operations; minimal broader regional effect.

Low; micro‑cap earnings unlikely to move major indices.

Counterpoint

Despite loss narrowing, revenue remains very low; the stock may still be overvalued.

Key entities

  • Future NRG Sdn. Bhd.

    Proposed merger partner; business combination agreement became effective in October.

  • Fitters Sdn. Bhd.

    Acquired in September 2025, contributes fire‑safety product revenue.

Related articles

$BGMSMed

BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update

Bio Green Med Solution, Inc. (BGMS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BIO GREEN MED SOLUTION Reports SECOND quarter financial results and provides business update KUALA LUMPUR, MALAYSIA, August 12, 2026 – Bio Green Med Solution, Inc. (NASDAQ: BGMS; “BGMS” or the “Company”), a diversified company engaged primarily in the provision of fi

$BGMSHighAI 9/10

Bio Green Med Solution Surges 172 % After Announcing Deal to Acquire Malaysia Waste Tech Company - Bio Gre

Bio Green Med Solution (NASDAQ:BGMS) shares rose about 123% to $2.35 after it signed an all-stock business combination agreement with Malaysia-based Future NRG. Future NRG will become a wholly owned BGMS subsidiary; the combined firm is expected to trade on Nasdaq under BGMS, led by Datuk Dr. Doris Wong Sing Ee. The deal is expected to close in Q4 2026, pending shareholder approval and SEC registration.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.